Mucolytics in the treatment of acute and chronic diseases of the nose and paranasal sinuses and nonpurulent middle ear disease in children

Abstract

By results of the studies performed by the World Health Organization recurrent respiratory infection (RRI) children experience more than 6 episodes of SARS per year. In the Russian Federation every 4th-5th child can be included in this group, which represents more than 60% of all diseases of childhood [1]. The most common pathologies in these children are acute respiratory viral infection followed by the addition of infectious and endocrine diseases. It must be remembered that recurrent respiratory infection children are characterized by a high incidence not only in the autumn-winter period but throughout the year, a prolonged duration of the inflammatory process, a tendency to recurrence or transition to a chronic form, resulting in special interest of practitioners to the treatment of such children and the disease prevention.